Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical Holdings Limited by way of a scheme of arrangement (the “Proposal”). Proposed privatisation of Kangji Medical Holdings Limited The Cancellation Price of HK$9.25 per share represents a 21.7% premium over the closing price on 30 June, 2025, being the Undisturbed Date, a 47.3% premium over the 360-trading day average closing price up to and incl...
Diagnostic imaging leads revenue surge; Novena centre expands reach in preventive healthcare ...
Funding boost to support pivotal trial and pre-commercialization of CLAAS® AcuFORM™ LAAO system. ...
With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage. ...
New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness. ...
Collaboration aims to develop next-generation endoluminal robotic platforms for enhanced precision and minimally invasive interventions in gastrointestinal care....
The platform sets out to transform India’s healthcare system by investing in high-impact solutions focused on access, affordability, and digital advancement. ...
SFPIM and Existing Shareholders Back Strategic Funding to Support Liver Disease Therapy Advancements....
New investment to accelerate global rollout of Koning’s 3D breast imaging technology....
Innovative high-frequency energy technology aims to revolutionize onychomycosis care with a drug-free, patient-friendly solution....
